<DOC>
	<DOC>NCT01486901</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to test for bioequivalence between two formulations of Insulatard® in healthy subjects.</brief_summary>
	<brief_title>Bioequivalence of Two Insulatard® Formulations in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Isophane insulin, beef</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Isophane Insulin, Human</mesh_term>
	<mesh_term>Insulin, Isophane</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Considered generally healthy upon completion of medical history and physical examination as judged by the Investigator Body Mass Index (BMI) between 18.0 and 27.0 kg/m^2, inclusive Nonsmoker, defined as no nicotine consumption for at least one year Fasting plasma glucose below or equal to 100 mg/dL (5.6 mmol/L) Previous participation in this trial or other clinical trials within the last 3 months Body weight above 87.5 kg Pregnant, breastfeeding or the intention of becoming pregnant or not using adequate contraceptive measures (intrauterine device (IUD) that has been in place for at least 3 months, or sterilisation, or the oral contraceptive pill, which should have been taken without difficulty for at least 3 months, an approved hormonal implant) History of alcohol or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>